Jakob Haldor Topsoe Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 hours ago
Jakob Haldor Topsoe has an estimated net worth of at least $13.0 million*, as of today. They own 10.5 million shares of IGMS stock. They have sold 0 shares of IGMS stock since 2021, for an estimated $-321,591.
Jakob Haldor Topsoe $IGMS SEC Form 4 Insider Trading
Jakob Haldor Topsoe has filed a total of 5 insider trades in $IGMS since 2021. Their most recent trade was a purchase of 3,500 shares, made on Jun 29, 2023. Their largest trade was a purchase of 8,254 shares, made on May 12, 2022. We estimate that they now own 10.5 million shares of $IGMS, worth an estimated $13.3 million.
Insider Trading at $IGMS
There have been a total of 162 insider trades reported at $IGMS since 2021, with 1.3 million shares purchased and 406,702 shares sold. The most active insider traders in $IGMS stock have been Bruce Keyt, George Gauthier, and Lisa Lynn Decker. The most recent trade was a sale of 8,741 shares reported by Misbah Tahir (CHIEF FINANCIAL OFFICER), made on Jul 23, 2025.
History of Insider Stock Trades by Jakob Haldor Topsoe
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
IGMS
|
Purchase | 3,500 | Jun 29, 2023 | July 3, 2023, 6:46 p.m. |
|
IGMS
|
Purchase | 3,500 | Jun 30, 2023 | July 3, 2023, 6:46 p.m. |
|
IGMS
|
Purchase | 1,481 | May 20, 2022 | May 24, 2022, 5:13 p.m. |
|
IGMS
|
Purchase | 8,254 | May 12, 2022 | May 15, 2022, 8 p.m. |
|
IGMS
|
Purchase | 7,850 | May 13, 2022 | May 15, 2022, 8 p.m. |
$IGMS Executives and Stock Owners with Insider Trades
-
Bruce Keyt, Chief Scientific Officer
-
George Gauthier, Chief Commercial Officer
-
Lisa Lynn Decker, Chief Business Officer
-
Misbah Tahir, Chief Financial Officer
-
Chris H Takimoto, Chief Medical Officer
-
Fred Schwarzer, CEO and President
-
Steven Weber, PRINCIPAL ACCOUNTING OFFICER
-
Lisa Lynn Decker, CHIEF BUSINESS OFFICER
-
Misbah Tahir, CHIEF FINANCIAL OFFICER
-
Bruce Keyt, CHIEF SCIENTIFIC OFFICER
-
Chris H Takimoto, CHIEF MEDICAL OFFICER
-
Fred Schwarzer, CEO AND PRESIDENT
-
Mary Beth Harler, Chief Executive Officer
-
Daniel Shinyu Chen, Chief Medical Officer
-
Mary Beth Harler, Head, Research & Autoimmunity
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.